Eidos Therapeutics Inc (EIDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EIDX | ALKS | VKTX | ||
| Company | Eidos Therapeutics Inc | Alkermes Plc | Viking Thera | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 127.57 | 29.54 | 41.94 | ||
| High | 128.49 | 29.77 | 43.24 | ||
| Low | 116.83 | 29.33 | 41.52 | ||
| Last | 122.21 | 29.73 | 42.71 | ||
| Change | -6.23 | +0.08 | +0.36 | ||
| % Change | -4.85% | +0.27% | +0.85% | ||
| Volume | 335,500 | 301,382 | 1,133,187 | ||
| 20-Day Average Volume | 113,985 | 1,572,688 | 3,527,787 | ||
| Previous Close | 128.44 | 29.65 | 42.35 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 124.59 | 30.24 | 47.33 | ||
| 20-Day Raw Stochastic | 36.63% | 30.39% | 28.15% | ||
| 20-Day Relative Strength | 56.42% | 52.14% | 36.51% | ||
| Weighted Alpha | +136.62 | +11.78 | -14.16 | ||
| Today's Opinion | 88% Buy | 88% Buy | 100% Sell | ||
| Previous Opinion | 100% Buy | 88% Buy | 100% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.40% since 01/15/21 | -1.13% since 12/18/24 | +11.19% since 12/18/24 | ||
| Low | 116.83 on 01/25/21 | 29.18 on 12/23/24 | 38.90 on 12/19/24 | ||
| High | 131.08 on 01/20/21 | 30.42 on 12/19/24 | 45.00 on 12/20/24 | ||
| 1-Month | |||||
| %Chg | -4.30% since 12/24/20 | +1.64% since 11/26/24 | -20.32% since 11/26/24 | ||
| Low | 116.24 on 01/05/21 | 28.63 on 11/27/24 | 37.80 on 12/18/24 | ||
| High | 132.54 on 01/04/21 | 32.25 on 12/09/24 | 54.73 on 11/27/24 | ||
| 3-Month | |||||
| %Chg | +66.75% since 10/23/20 | +9.42% since 09/26/24 | -31.70% since 09/26/24 | ||
| Low | 69.38 on 10/30/20 | 25.67 on 10/31/24 | 37.80 on 12/18/24 | ||
| High | 132.54 on 01/04/21 | 32.25 on 12/09/24 | 81.73 on 10/28/24 | ||
| 6-Month | |||||
| %Chg | +178.07% since 07/24/20 | +21.00% since 06/26/24 | -10.18% since 06/26/24 | ||
| Low | 38.44 on 07/31/20 | 22.90 on 07/10/24 | 37.80 on 12/18/24 | ||
| High | 132.54 on 01/04/21 | 32.25 on 12/09/24 | 81.73 on 10/28/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,750,670 | 4,797,459 | 4,719,314 | ||
| Shares Outstanding, K | 38,873 | 161,803 | 111,436 | ||
| Annual Sales | 26,690,000 | 1,663,410,000 | 0 | ||
| Annual Net Income | -37,840,000 | 355,760,000 | -85,900,000 | ||
| Last Quarter Sales | 130,000 | 378,140,000 | 0 | ||
| Last Quarter Net Income | -30,180,000 | 92,380,000 | -24,940,000 | ||
| 60-Month Beta | -0.16 | 0.49 | 0.88 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.73 on 10/24/24 | -0.22 on 10/23/24 | ||
| Latest Earnings Date | 02/24/21 | 10/24/24 | 02/05/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.03 | 0.00 | ||